The outbreaks — one in Equatorial Guinea and one in Tanzania — were linked to animal-to-human spillover events, according to the CDC. Rising case counts in both countries caused the World Health Organization to declare the events “outbreaks” in February. Now, the outbreaks have grown to levels not seen in Africa years and are “among the largest on the continent in a decade,” CBS News reported.
The virus is spread through direct contact with the bodily fluid of infected persons and unlike some viruses, does not spread through the air.
“There is currently no Food and Drug Administration-approved vaccine or treatment for [Marburg virus disease],” the CDC’s alert states. “In the absence of early diagnosis and appropriate supportive care, MVD has a high mortality rate of 23-90 percent. With early intensive supportive care and fluid replacement, mortality rates may be lower.”
Clinicians are advised to thoroughly assess patients who may show signs of infection and ask for their detailed travel history, as some cases could enter the U.S. via travelers.
While no cases have yet been identified in the U.S. or countries other than the two experiencing the outbreak, the CDC noted that its advisory is to “increase awareness” about the possibility and risk of imported cases in the U.S.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
